Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2012 Mar 20;8(5):581–595. doi: 10.1517/17425255.2012.673585

Figure 2.

Figure 2

Receptor binding and pharmacokinetic properties of various transferrin-fusion proteins. Fusion proteins with different linkers were recombinantly produced inHEK293 cells. IC50 values from competitive receptor binding assays were performed in IM-9 cells for GH receptor (GHR), NSF-60 cells for G-CSF receptor (G-CSFR), and Caco-2 cells for Tf receptor (TfR) using 125I-labeled proteins. The half-life values were determined following intravenous administration of fusion proteins to CF1 mice in the absence and presence of co-administered GH or Tf. The values represent mean ± standard deviation (n=3 to 4).